Vascular angiotensin II type 2 receptor attenuates atherosclerosis via a kinin/NO-dependent mechanism

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 16, Issue 2, 2015, Pages 311-320

  Takata, Hiroki ^a   Yamada, Hiroyuki ^a   Kawahito, Hiroyuki ^a   Kishida, Sou ^a   Irie, Daisuke ^a   Kato, Taku ^a   Wakana, Noriyuki ^a   Miyagawa, Sonoko ^a   Fukui, Kensuke ^a   Matsubara, Hiroaki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Angiotensin; atherosclerosis; nitric oxide; oxidative stress; receptor

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; BRADYKININ B2 RECEPTOR; HYDROETHIDINE; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; VASCULAR CELL ADHESION MOLECULE 1; ANGIOTENSIN II; APOLIPOPROTEIN E; BRADYKININ; CALCIUM; ICATIBANT; KININ; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BIOACCUMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME MECHANISM; LEUKOCYTE; MACROPHAGE; MALE; MONOCYTE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; VASCULAR SMOOTH MUSCLE CELL; ANALOGS AND DERIVATIVES; ANIMAL; AORTA; C57BL MOUSE; DEFICIENCY; DRUG EFFECTS; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; TRANSGENIC MOUSE;

ANGIOTENSIN II; ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BRADYKININ; CALCIUM; KININS; MACROPHAGES; MICE, INBRED C57BL; MICE, TRANSGENIC; MONOCYTES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; OXIDATIVE STRESS; RECEPTOR, ANGIOTENSIN, TYPE 2; SUPEROXIDES; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84930911739     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320313491794     Document Type: Article

References (34)

1. Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest. 2000 ; 105: 1605-1612
2. Weiss D, Kools JJ, Taylor WR. Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice. Circulation. 2001 ; 103: 448-454
3. Østerud B, Bjorklid E. Role of monocytes in atherogenesis. Physiol Rev. 2003 ; 83: 1069-1112
4. Griendling KK, Minieri CA, Ollerenshaw JD, et al. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994 ; 74: 1141-1148
5. Griendling KK, Sorescu D, Lassègue B, et al. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol. 2000 ; 20: 2175-2183
6. Irani K. Oxidant signaling in vascular cell growth, death, and survival. A review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res. 2000 ; 87: 179-183
7. Daugherty A, Manning MW, Cassis LA. Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Brit J Pharmacol 2001. 134: 865-870
8. Daugherty A, Rateri DL, Lu H, et al. Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor. Circulation. 2004 ; 110: 3849-3857
9. Iwai M, Chen R, Li Z, et al. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice. Circulation. 2005 ; 112: 1636-1643
10. Wan Y, Wallinder C, Plouffe B, et al. Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. J Med Chem. 2004 ; 47: 5995-6008
11. Horiuchi M, Akishita M, Dzau VJ. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension. 1999 ; 33: 613-621
12. Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res. 1998 ; 83: 1182-1191
13. Lévy BI. Can angiotensin II type 2 receptors have deleterious effects in cardiovascular disease? Implications for therapeutic blockade of the renin-angiotensin system. Circulation. 2004 ; 109: 8-13
14. Utsunomiya H, Nakamura M, Kakudo K, et al. Angiotensin II AT2 receptor localization in cardiovascular tissues by its antibody developed in AT2 gene-deleted mice. Regul Peptides. 2005 ; 126: 155-161
15. Sales VL, Sukhova GK, Lopez-Ilasaca MA, et al. Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution. Circulation. 2005 ; 112: 3328-3336
16. Tsutsumi Y, Matsubara H, Masaki H, et al. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest. 1999 ; 104: 925-935
17. Masaki H, Kurihara T, Yamaki A, et al. Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. J Clin Invest. 1998 ; 101: 527-535
18. Ozaki M, Kawashima S, Yamashita T, et al. Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. J Clin Invest. 2002 ; 110: 331-340
19. Miller FJ, Gutterman DD, Rios CD, et al. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res. 1998 ; 82: 1298-1305
20. Matsuno K, Yamada H, Iwata K, et al. Nox1 is involved in angiotensin II-mediated hypertension: A study in Nox1-deficient mice. Circulation. 2005 ; 112: 2677-2685
21. Moreno C, Lopez A, Llamas MT, et al. Changes in NOS activity and protein expression during acute and prolonged Ang II administration. Am J Physiol. 2002 ; 282: R31 - R37
22. Galkina E, Ley K. Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol. 2007 ; 27: 2292-2301
23. Khan BV, Harrison DG, Olbrych MT, et al. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci USA. 1996 ; 93: 9114-9119
24. Tummala PE, Chen X, Sundell CL, et al. Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis. Circulation. 1999 ; 100: 1223-1229
25. Bedard K, Krause KH. The Nox family of ROS-generating NADPH oxidase: Physiology and pathophysiology. Physiol Rev. 2007 ; 87: 245-313
26. Carey RM, Jin XH, Siragy HM. Role of the angiotensin AT2 receptor in blood pressure regulation and therapeutic implications. Am J Hypertens. 2001 ; 14: 98S - 102S
27. Stoll M, Steckelings UM, Paul M, et al. The angiotensin AT2-receptor mediated inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 1995 ; 95: 651-657
28. Matsubara H, Sugaya T, Murasawa S, et al. Tissue-specific expression of human angiotensin II AT1 and AT2 receptors and cellular localization of subtype mRNA in adult human renal cortex using in situ hybridization. Nephron. 1998 ; 80: 25-34
29. Bagby SP, LeBard LS, Luo Z, et al. Angiotensin II type 1 and 2 receptors in conduit arteries of normal developing microswine. Arterioscler Thromb Vasc Biol. 2002 ; 22: 1113-1121
30. d'Uscio LV, Baker TA, Mantilla CB, et al. Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2001 ; 21: 1017-1022
31. d'Uscio LV, Smith LA, Katusic ZS. Hypercholesterolemia impairs endothelium-dependent relaxations in common carotid arteries of apolipoprotein E-deficient mice. Stroke. 2001 ; 32: 2658-2664
32. Chabrashvili T, Kitiyakara C, Blau J, et al. Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am J Physiol. 2003 ; 285: R117 - R124
33. Kaschina E, Grzesiak A, Li J, et al. Angiotensin II type 2 receptor stimulation: a novel option of therapeutic interference with the renin-angiotensin system in myocardial infarction?. Circulation. 2008 ; 118: 2523-2532
34. Rehman A, Leibowitz A, Yamamoto N, et al. Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats. Hypertension. 2012 ; 59: 291-299